Список проголосовавших за комментарий " On The Wires<ul><li>On March 20, 2017, Enstar Group (<strong>ESGR</strong>) exercised the accordion feature available under its amended and restated $665 million Revolving Credit Facility. This increased the total commitments under the Facility by $166.25 million, bringing the total amount available under the Facility to an aggregate principal amount of $831.25 million. The additional commitments were obtained from two new lenders. All other terms of the Facility remain unchanged. Following this increase, as of March 20, 2017, the Company had $585.82 million of available unutilized capacity under the Facility.</li><li>Benitec Biopharma Limited (<strong>BNTC</strong>) advises that it has received a AUD$5,590,235 cash refund under the Federal Government's R&D Tax Incentive Scheme. The refund relates to the costs of research and development which qualify as eligible R&D expenditure under the Federal Government's Scheme. The funds will be used to advance Benitec's human therapeutic programs in gene silencing.</li></ul>"